SEC Form 4 · accession 0001209191-17-015448
BIOCEPT INC · BIOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J Terry
Officer — Sr VP Comm. Operations
Period of report
Feb 28, 2017
Accepted (ET)
Feb 28, 2017 · 6:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001044378
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $2.05 | Feb 28, 2017 | A | 50,000 | A | — | Feb 27, 2027 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F125% of the shares subject to the option shall vest on the first annual anniversary of the Vesting Commencement Date (2/28/17) with the balance vesting in equal quarterly installments over the following three years until fully vested on February 28, 2021.